生殖醫(yī)學(xué)領(lǐng)域規(guī)模最大、最具影響力的國(guó)際會(huì)議——美國(guó)生殖醫(yī)學(xué)會(huì)（ASRM）2024年年會(huì)在美國(guó)科羅拉多州丹佛市圓滿落幕。來(lái)自90多個(gè)國(guó)家和地區(qū)的5000余名專家學(xué)者齊??聚一堂，共同探討生殖醫(yī)學(xué)學(xué)術(shù)挑戰(zhàn)、分享臨床經(jīng)驗(yàn)、探索前沿技術(shù)新方向。 女?huà)z生命參加此次會(huì)議，展示了其首創(chuàng)的表觀遺傳檢測(cè)技術(shù)——植入前甲基化篩查（PIMS），并受邀做主題演講。此外，該公司還榮獲 ASRM 頒發(fā)的 2024 年生殖生物學(xué)與技術(shù)學(xué)會(huì) (SRBT) 獎(jiǎng)。   會(huì)議期間，PIMS產(chǎn)品和技術(shù)獲得了全球生殖行業(yè)領(lǐng)導(dǎo)者、潛在合作伙伴和客戶的高度關(guān)注和認(rèn)可。女?huà)z團(tuán)隊(duì)通過(guò)互動(dòng)與行業(yè)專家和與會(huì)者建立聯(lián)系，獲得對(duì)市場(chǎng)需求的寶貴見(jiàn)解并了解新技術(shù)趨勢(shì)。這些信息將幫助女?huà)z更好地了解行業(yè)趨勢(shì)并完善其產(chǎn)品，使其更貼近市場(chǎng)需求。     女?huà)z生命高級(jí)研發(fā)總監(jiān)姚雪龍博士受邀發(fā)表題為“ 輔助生殖技術(shù)中評(píng)估胚胎質(zhì)量的一種新方法： DNA甲基化”的主題演講。 他被美國(guó)生殖醫(yī)學(xué)會(huì)（ASRM）授予2024年生殖生物學(xué)與技術(shù)學(xué)...

On August 23rd, the winners of the HICOOL 2024 Global Entrepreneurship Competition were announced at the HICOOL 2024 Global Entrepreneurs Summit. The "Pioneering Application of Epigenetics in Reproductive Medicine" project by Nuwa Life won the third prize! In this grand gathering of global wisdom, we competed with 7,406 projects and 9,700 top innovators from 124 countries and regions, showcasing our strength and innovative spirit. Receiving recognition on such an international stage is a high affirmation of our potential for future development, and we are deeply honored. We thank every partner who supports us and every team member for their hard work and relentless pursuit. It is your creativity and efforts that have made this moment possible. This honor belongs to each of us and is the result of our joint struggle. We will continue to uphold the spirit ...

In December 2021,  Guangzhou Nvwa Life Technology Co., Ltd. signed strategic cooperation agreements with CITIC Xiangya Genetics and Reproductive Specialist Hospital, the University of Hong Kong Shenzhen Hospital, and Shenyang Shengjing Hospital, aiming to cooperate in national scientific programs, research and development, and clinical trials.

The 2021 Huangpu District Leading Talent Competition was officially launched on October 25. High-level technology talents from 79 companies in the district competed for the award. After rounds of fierce competition, the founder of  Guangzhou Nvwa Life Technology Co., Ltd. was selected as one of the awardees in Huangpu District, Guangzhou.

21st October, 2021, the biomedical final competition of the 10th China and the sixth Guangzhou Innovation and Entrepreneurship Competition was held in Huangpu District. Guangzhou Nvwa Life Technology Co., Ltd. was awarded the third out of 122 companies in biomedical field.  

On 18th August,2021, Guangzhou NVWA life Technology Co., Ltd. , a new generation assisted reproductive technology innovation company (hereinafter referred to as “Nvwa life”) has successfully completed tens of millions of RMB in angel round financing, exclusively led by JUE Capital. In China, the low birth rate has become a major concern for China’s future economic and social development. With the implementation of supportive policies for the second and third child, many related fields have attracted attention, and the assisted reproductive market has become ont of the most attractive. The political bureau of central committee of Chinese Communist Party held a meeting to deliberate on The Decision On Optimization Of Reproduction Policy To Advance Population For Long-term and Balanced Development, on 31st May,2021. The meeting poi...